4Citron ML,Berry DA,Cirrincione C,et al.Randomized trial of dose - dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node - positive primary breast cancer:first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 [J].J Clin Oncol,2003;21 (8):1431 -1439.
5Fisher B,Brown A,Makounas E,et al.Effect of preoperative chemotherapy on local - regional disease in women with operable breast cancer:findings from National Surgical Adjuvant Breast and Bowel Project B - 18.J Clin Oncol,1997;15(7):2483 - 2493.
6Seidman AD,Tiersten A,Hudis C,et al.Phase Ⅱ trial of paclitaxel by 3 - hour infusion as initial and salvage chemotherapy for metastatic breast cancer[J].J Clin Oncol,1995; 13(10) :2575 -2581.
7Sato KS,Inoue K,Saito T,et al.Multicerter phase Ⅱ trial of weekly paclitaxel for advanced or metastatic breast cancer:the saitama breast cancer clinical study group(SBCCSG -01).Jpn J Clin Oncol,2003 ;33 (8) :371 - 376.
8Sledge GW,Neuberg D,Bermardo P,et al.Phase Ⅲ trial or doxorubicin,paclitaxel,and the combination or doxorubicin and paclitaxel as front - line chemotherapy for metastatic breast cancer:an intergroup trial(E1193 [J]).J Clin Oncol,2003 ;21(4) :588 -592.
9Winer EP,Berry DA,Woolf S,et al.Failure of higher -dose paclitaxel to improve outcome in patients with metastatic breast cancer:cancer and leukemia group B trial 9342 [J].J Clin Oncol,2004,22(11) :2061 -2168.
10Gori S,Mosconi AM,Basurtol C,et al.Weekly paclitaxel in metastatic breast cancer patients:a phase Ⅱ study[J].Tumori,2002 ;88 (6) :470 ～ 473.
